SHJB.F Stock Overview
A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Shanghai Junshi Biosciences Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.24 |
| 52 Week High | HK$2.06 |
| 52 Week Low | HK$0.95 |
| Beta | 0.41 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -89.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHJB.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -3.7% | 0.3% |
| 1Y | n/a | 15.2% | 31.1% |
Return vs Industry: Insufficient data to determine how SHJB.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how SHJB.F performed against the US Market.
Price Volatility
| SHJB.F volatility | |
|---|---|
| SHJB.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.8% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SHJB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine SHJB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 2,532 | Cong Li | www.junshipharma.com |
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People’s Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People’s Republic of China.
Shanghai Junshi Biosciences Co., Ltd. Fundamentals Summary
| SHJB.F fundamental statistics | |
|---|---|
| Market cap | US$3.63b |
| Earnings (TTM) | -US$249.03m |
| Revenue (TTM) | US$246.81m |
6.7x
P/S Ratio-6.6x
P/E RatioIs SHJB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHJB.F income statement (TTM) | |
|---|---|
| Revenue | CN¥1.79b |
| Cost of Revenue | CN¥622.89m |
| Gross Profit | CN¥1.16b |
| Other Expenses | CN¥2.97b |
| Earnings | -CN¥1.80b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.83 |
| Gross Margin | 65.15% |
| Net Profit Margin | -100.90% |
| Debt/Equity Ratio | 43.8% |
How did SHJB.F perform over the long term?
See historical performance and comparison